Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
08/2003
08/14/2003WO2003066849A2 Novel purified polypeptides from staphylococcus aureus
08/14/2003WO2003066848A1 Porcine fgl2
08/14/2003WO2003066847A2 Phytase variants
08/14/2003WO2003066846A1 Methods for modifying plant responses to stress and correspondingly derived plants
08/14/2003WO2003066845A2 Bacteriophage lysin
08/14/2003WO2003066844A2 Cytochrome p450 protein
08/14/2003WO2003066842A2 Method for producing recombinant proteins in micro-organisms
08/14/2003WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003WO2003066836A2 Udp-glucosyltransferases
08/14/2003WO2003066835A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066821A2 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
08/14/2003WO2003066819A2 A novel artemis/dna-dependent protein kinase complex and methods of use thereof
08/14/2003WO2003066818A2 Secretion, transcription and sporulation genes in bacillus clausii
08/14/2003WO2003066815A2 Method for producing 2-hydroxyisobutyric acid and methacrylic acid from acetone cyanohydrin
08/14/2003WO2003066809A2 Mismatch endonucleases and methods of use
08/14/2003WO2003066804A2 Thermus scotoductus nucleic acid polymerases
08/14/2003WO2003066668A2 Peptide deformylase
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066048A2 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003065978A2 Crystals and structures of a flavin mononucleotide binding protein (fmnbp)
08/14/2003WO2003065795A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
08/14/2003WO2003050240A3 Expression system
08/14/2003WO2003048309A3 Thermus thermophilus nucleic acid polymerases
08/14/2003WO2003040352A9 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
08/14/2003WO2003033725A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003026395A3 Mo54 gene disruptions, compositions and methods related thereto
08/14/2003WO2003025118A3 Multi-site mutagenesis
08/14/2003WO2003018764A3 Novel human proteases and polynucleotides encoding the same
08/14/2003WO2003010184A3 A conserved xiap-interaction motif in caspase-9 and smac/diablo for mediating apoptosis
08/14/2003WO2003008563A9 Improved cytochrome p450 oxygenases
08/14/2003WO2002088341A3 P450 proteins
08/14/2003WO2002051439A3 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
08/14/2003WO2002033060A3 Nucleic acid sequences to proteins involved in tocopherol synthesis
08/14/2003WO2002031130A9 Manipulation of soluble carbohydrates
08/14/2003WO2002029079A3 Enantioselective production of amino carboxylic acids
08/14/2003WO2002024867A3 Novel compositions and methods for lymphoma and leukemia
08/14/2003WO2002020733A3 Genes involved in isoprenoid compound production
08/14/2003WO2002020475A3 Inhibitors of serine protease activity of matriptase or mtsp1
08/14/2003WO2002009295A3 Plant acyl-coa synthetases
08/14/2003WO2002003787A3 Transgenic mice containing targeted gene disruptions
08/14/2003US20030154515 Triacylglycerol lipases
08/14/2003US20030154513 Which are associated with tocopherol biosynthesis; for addition to feedstocks
08/14/2003US20030154507 Comprises DNA that codes for enzyme which degrades 2,4-dichlorophenoxyacetic acid to dichlorophenol; weed control; auxins
08/14/2003US20030154505 Transgenic non-human mammal with an oncogenic mutant of the c-Raf-1 gene
08/14/2003US20030154504 Methods and compositions for modulating carbohydrate metabolism
08/14/2003US20030154503 Cathepsin G (CTSG) disruptions, compositions and methods relating thereto
08/14/2003US20030154501 Analyzing effects of insecticides on gut of nematodes via high throughput assay
08/14/2003US20030154500 Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
08/14/2003US20030153739 Formed via cloning and expressing cDNA, then detecting missense mutations with immunoassay
08/14/2003US20030153738 Homologs of bacterial AlkB gene (hABH); receptor binding assay; for repairing alkylated DNA, preventing/treating cell death/cancer
08/14/2003US20030153549 Clavulinic acid derivatives; antibiotics
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153097 Modulation of COP9 signalsome isopeptidase activity
08/14/2003US20030153076 Mammalian telomerase
08/14/2003US20030153064 A novel member of disintegrin Proteases, used for delivery and therapeutics
08/14/2003US20030153062 Twenty-one butyrylcholinesterase variant polypeptides having increased cocaine hydrolysis activity comparted to naturally occurring human butyrylcholinesterase
08/14/2003US20030153060 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto
08/14/2003US20030153058 A gene coding for glutamate dehydrogenase is introduced into a microorganism having L-arginine producing ability to enhance intracellular glutamate dehydrogenase activity and thereby improve the L-arginine producing ability
08/14/2003US20030153052 Diterpene cyclase and methods of use
08/14/2003US20030153051 Cholesterol oxidase
08/14/2003US20030153042 Expression of functional eukaryotic proteins
08/14/2003US20030153037 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153036 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030153020 Classification of signal of peptidoglycan; drug screening
08/14/2003US20030153015 Compositions and methods for the treatment of immune related diseases
08/14/2003US20030153000 Genetic engineering; culture product; recovering
08/14/2003US20030152999 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152988 Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescent dyes
08/14/2003US20030152986 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
08/14/2003US20030152983 Desaturase
08/14/2003US20030152971 Methods and compositions for detecting target sequences
08/14/2003US20030152968 Methods for detection of promoter polymorphism in a UGT gene promoter
08/14/2003US20030152949 Phosphatases
08/14/2003US20030152922 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152915 Recombinant Hepatitis C virus RNA replicase
08/14/2003US20030152567 Protease for activating clotting factor VII
08/14/2003US20030152563 Administering plasminogen activator; biocompatiblity coupling to red blood carrier; drug delivery
08/14/2003US20030152560 Therapy for Fabry's disease; genetic engineering; cloning; gene therapy
08/14/2003US20030152557 Methods for inhibiting histone deacetylase-4
08/14/2003US20030152553 Transfection, transduction of cells
08/14/2003CA2697599A1 Method of treating and preventing bone loss
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475446A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475277A1 Method for producing recombinant proteins in micro-organisms
08/14/2003CA2475271A1 Method for producing 2-hydroxyisobutyric acid and methacrylic acid from acetone cyanohydrin
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475230A1 Cytochrome p450 protein
08/14/2003CA2475095A1 Degradation of hydrophobic ester pesticides and toxins
08/14/2003CA2475094A1 Esterases with lipase activity
1 ... 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 ... 1416